Anti-PCSK9/ FH3/ HCHOLA3 monoclonal antibody

Anti-PCSK9/ FH3/ HCHOLA3 antibody for FACS & in-vivo assay

Target products collectionGo to PCSK9/PCSK9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62206-Ab-1/ GM-Tg-hg-T62206-Ab-2Anti-Human PCSK9 monoclonal antibodyHuman
GM-Tg-rg-T62206-Ab-1/ GM-Tg-rg-T62206-Ab-2Anti-Rat PCSK9 monoclonal antibodyRat
GM-Tg-mg-T62206-Ab-1/ GM-Tg-mg-T62206-Ab-2Anti-Mouse PCSK9 monoclonal antibodyMouse
GM-Tg-cynog-T62206-Ab-1/ GM-Tg-cynog-T62206-Ab-2Anti-Cynomolgus/ Rhesus macaque PCSK9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62206-Ab-1/ GM-Tg-felg-T62206-Ab-2Anti-Feline PCSK9 monoclonal antibodyFeline
GM-Tg-cang-T62206-Ab-1/ GM-Tg-cang-T62206-Ab-2Anti-Canine PCSK9 monoclonal antibodyCanine
GM-Tg-bovg-T62206-Ab-1/ GM-Tg-bovg-T62206-Ab-2Anti-Bovine PCSK9 monoclonal antibodyBovine
GM-Tg-equg-T62206-Ab-1/ GM-Tg-equg-T62206-Ab-2Anti-Equine PCSK9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62206-Ab-1/ GM-Tg-hg-T62206-Ab-2; GM-Tg-rg-T62206-Ab-1/ GM-Tg-rg-T62206-Ab-2;
GM-Tg-mg-T62206-Ab-1/ GM-Tg-mg-T62206-Ab-2; GM-Tg-cynog-T62206-Ab-1/ GM-Tg-cynog-T62206-Ab-2;
GM-Tg-felg-T62206-Ab-1/ GM-Tg-felg-T62206-Ab-2; GM-Tg-cang-T62206-Ab-1/ GM-Tg-cang-T62206-Ab-2;
GM-Tg-bovg-T62206-Ab-1/ GM-Tg-bovg-T62206-Ab-2; GM-Tg-equg-T62206-Ab-1/ GM-Tg-equg-T62206-Ab-2
Products NameAnti-PCSK9 monoclonal antibody
Formatmab
Target NamePCSK9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PCSK9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-077Pre-Made Bococizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-016Pre-Made Alirocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-163Pre-Made Ebronucimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-467Pre-Made Ralpancizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-318Pre-Made Lodelcizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-403Pre-Made Ongericimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-473Pre-Made Recaticimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-544Pre-Made Tafolecimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-202Pre-Made Evolocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-ab-224Pre-Made Frovocimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody
    BiosimilarGMP-Bios-INN-890Pre-Made Lerodalcibep Biosimilar, Fusion Protein targeting PCSK9 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
    Target AntigenProducts DevelopingMulti-species PCSK9/ FH3/ HCHOLA3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000015human PCSK9 Lentivirus plasmid
    ORF Viral VectorvGMLV000015human PCSK9 Lentivirus particle
    ORF Viral VectorpGMAAV000098mouse Pcsk9 AAV plasmid
    ORF Viral VectorpGMAAV000099mouse Pcsk9 AAV plasmid
    ORF Viral VectorpGMAAV000199house mouse Pcsk9 AAV plasmid
    ORF Viral VectorpGMAAV000299house mouse Pcsk9 AAV plasmid
    ORF Viral VectorvGMAAV000098mouse Pcsk9 AAV particle
    ORF Viral VectorvGMAAV000099mouse Pcsk9 AAV particle
    ORF Viral VectorvGMAAV000199house mouse Pcsk9 AAV particle
    ORF Viral VectorvGMAAV000299house mouse Pcsk9 AAV particle


    Target information

    Target IDGM-T62206
    Target NamePCSK9
    Gene ID255738,100102,298296,717147,100147049
    Gene Symbol and SynonymsFH3,FHCL3,HCHOLA3,LDLCQ1,NARC-1,NARC1,PC9,PCSK9
    Uniprot AccessionQ8NBP7,P59996,A8T666
    Uniprot Entry NamePCSK9_HUMAN,PCSK9_MACMU,PCSK9_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    DiseaseOvary Cancer
    Gene EnsemblENSG00000169174
    Target ClassificationN/A

    The target: PCSK9, gene name: PCSK9, also named as FH3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9. This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.